21199 ⎘
Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant; Organic adjuvants Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
CH505 ENVELOPES TO ENGAGE AND MATURE CD4 BINDING SITE NEUTRALIZING ANTIBODIES
#2POLYMERIC NANOVACCINES AND USES THEREOF
#3METHODS FOR ASSEMBLING PROTEIN-CONJUGATED NANOCARRIER VACCINES
#4Methods for the Rapid Manufacture of Conjugate Vaccines that Elicit Robust Immune Responses
#5VACCINE COMPRISING PERIPHERAL BLOOD MONONUCLEAR CELLS LOADED WITH NATURAL KILLER T CELL LIGAND AND ANTIGEN
#6METHODS AND COMPOSITIONS RELATING TO THE SYNTHESIS OF THE QS-7 MOLECULE
#7VACCINES TARGETING C. ACNES HYALURONIDASE FOR PROPHYLAXIS AND TREATMENT OF ACNE VULGARIS
#8ENVELOPED VIRUS LIKE PARTICLES COMRISING SARS-COV-2 S PROTEIN
#9RSV VACCINATION WITH TRIMERIC RSV F FUSION PROTEIN
#10METHODS AND COMPOSITIONS FOR MODULATION OF IMMUNE RESPONSES
#11USE OF MATRIX BOUND VESICLES (MBV) AS VACCINE ADJUVANTS
#12COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS
#13CANCER ANTIGENS AND METHODS
#145'-UTR WITH IMPROVED TRANSLATION EFFICIENCY, A SYNTHETIC NUCLEIC ACID MOLECULE INCLUDING THE SAME, AND A VACCINE OR THERAPEUTIC COMPOSITION INCLUDING THE SAME
#15CD44 GLYCOEPITOPES AND CHIMERIC VACCINE GLYCOCONJUGATES FOR CANCER THERAPY AND SYNTHESIS METHODS THEREOF
#16Compositions of Phosphorylated Tau Peptides and Uses Thereof
#17USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#18Vaccines and Antibodies for the Treatment and Prevention of Microbial Infections
#19SINGLE VIAL VACCINE FORMULATIONS
#20Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#21IMMUNOGENIC COMPOSITION WITH PROTEIN MICRO- AND NANOPARTICLES
#22STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS
#23PREVENTION AND TREATMENT OF INFECTIONS WITH INTRACELLULAR BACTERIA
#24Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#25ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF
#26METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING ANUCLEATE CELLS
#27PNEUMOCOCCAL CONJUGATE VACCINES AND METHODS OF USE THEREOF
#28FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#29COMPLETE TOLEROGENIC ADJUVANT AND METHODS OF USING THE SAME
#30DENDRITIC CELL TARGETING FILAMENTOUS PHAGE-BASED CANCER TREATMENT VACCINE
#31RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT FUSION PROTEIN WITH PRE-FUSION CONFORMATION, PREPARATION METHOD AND USES THEREOF
#32PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS
#33VACCINE CONSTRUCT AND USES THEREOF
#34ANTHRAX VACCINE
#35MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#36TRIPLE VACCINE PROTECTS AGAINST BACTERIAL AND FUNGAL PATHOGENS VIA TRAINED IMMUNITY
#37METHODS FOR PRODUCING AN ADJUVANT
#38Multivalent Vaccine Compositions
#39NKT CELL LIGAND-CONTAINING LIPOSOME COMPOSITION
#40Anti-Alpha-Synuclein Therapeutic Vaccines
#41LIPOSOMES CONTAINING PHOSPHORYLATED TAU PEPTIDES FOR INDUCING SUSTAINED IMMUNE RESPONSES
#42HEPATITIS C VIRUS E1/E2 HETERODIMERS AND METHODS OF PRODUCING SAME
#43MONOPHOSPHORYL LIPID ADJUVANT (MPLA) COMPOSITIONS, VACCINE COMPOSITIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME
#44Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses
#45USE OF VARIOVORAX MICROBES AS AN ALTERNATIVE TREATMENT FOR COCCIDIOSIS
#46METHOD OF TREATING PRECLINICIAL ALZHEIMER'S DISEASE
#47OIL-BASED ADJUVANTS
#48POLYMER ADJUVANT
#49COMPOSITION FOR ENHANCING IMMUNOGENICITY
#50FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF
#51RECOMBINANT MULTIVALENT VACCINE
#52TLR8 AGONIST FOR MODULATING IMMUNE RESPONSE
#53Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists
#54METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY
#55PRO-INFLAMMATORY AND ANTI-CANCER FUNCTIONS OF TOLL-LIKE RECEPTOR 4 ANTAGONISTS
#56MUCOSAL VACCINE, METHODS OF USE AND ADMINISTRATION THEREOF
#57ENGINEERING ANTIGEN BINDING TO, AND ORIENTATION ON, ADJUVANTS FOR ENHANCED HUMORAL RESPONSES AND IMMUNOFOCUSING
#58NEMATODE VACCINE
#59HBV VACCINE INDUCING PRES-SPECIFIC NEUTRALIZING ANTIBODIES
#60HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS
#61METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTICMICROBIAL THERAPEUTICS
#62Novel Adjuvant Compositions
#63Multivalent Epstein-Barr virus-like particles and uses thereof
#64Shigella Vaccine
#65IMMUNE PRIMING TO ACCELERATE/ENHANCE IMMUNE RESPONSE THROUGH ADMINISTRATION OF NATURAL IMMUNE MODULATOR
#66Anti-Abeta Therapeutic Vaccines
#67Multi-epitope vaccine for the treatment of Alzheimer's disease
#68RNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES AND ITS FORMULATIONS
#69NON-HLA RESTRICTED T CELL VACCINE FOR TCR GAMMA ALTERNATE READING FRAME PROTEIN (TARP) PROTEIN EXPRESSING CANCERS
#70SARS-COV-2 SUBUNIT VACCINE
#71Method of Conferring a Protective Immune Response to Norovirus
#72ADJUVANTED VACCINES WITH NON-VIRION ANTIGENS PREPARED FROM INFLUENZA VIRUSES GROWN IN CELL CULTURE
#73SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT
#74NOVEL METHODS FOR MANUFACTURING AN ADJUVANT
#75LEPTOSPIRAL VIRULENCE MODULATING PROTEINS AND USES THEREOF
#76COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE
#77AMINO ACIDS, NUCLEOTIDES AND VECTORS EXPRESSING THE SAME AND USES THEREOF IN PREVENTING SARBECOVIRUS INFECTION
#78A BROADLY PROTECTIVE PROPHYLACTIC VACCINE AGAINST PSEUDOMONAS AERUGINOSA
#79HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#80ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#81PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE
#82HUMAN METAPNEUMO VIRUS VACCINE
#83Compositions and Methods to Enhance Therapeutic Efficacy of Cancer Therapies
#84IMMUNOGENIC COMPOSITION, USE AND METHODS
#85Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines
#86Periodontitis vaccine and related compositions and methods of use
#87Compositions, methods and uses for thermally stable multi-targeted antigens
#88Novel Antigens
#89FORMULATIONS AND METHODS FOR MHC-I RESTRICTED EPITOPE IMMUNIZATION
#90ADJUVANT COMPRISING A GLYCOARCHAEOL AND AN IMMUNOSTIMULANT
#91VACCINE COMPOSITION FOR CHICKENPOX OR VARICELLA ZOSTER AND METHOD OF USING SAME
#92Vaccine Composition for Preventing Tuberculosis Comprising Chorismate Mutase
#93Oil-based adjuvants
#94Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#95ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#96MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#97RSV F protein compositions and methods for making same
#98Triple vaccine protects against bacterial and fungal pathogens via trained immunity
#99VACCINES AGAINST VIRAL PATHOGENS
#100Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses
#101Coronavirus disease (COVID-19) vaccine
#102SINGLE-CHAIN CORONAVIRUS VIRAL MEMBRANE PROTEIN COMPLEXES
#103Multi-epitope vaccine for the treatment of Alzheimer's disease
#104Multi-epitope vaccine for the treatment of Alzheimer's disease
#105RECOMBINANT SARS-COV-2 SPIKE PROTEIN SUBUNITS, EXPRESSION AND USES THEREOF
#106Multi-epitope vaccine for the treatment of Alzheimer's disease
#107FcRn-targeted mucosal vaccination against influenza infections
#108VACCINE COMPOSITION COMPRISING PLANT-EXPRESSED RECOMBINANT ZIKA VIRUS ENVELOPE PROTEIN AND PREPARATION METHOD THEREFOR
#109SINGLE VIAL VACCINE FORMULATIONS
#110LIPIDS AS SYNTHETIC VECTORS TO ENHANCE ANTIGEN PROCESSING AND PRESENTATION EX-VIVO IN DENDRITIC CELL THERAPY
#111Coronavirus Vaccine
#112NOVEL VACCINE COMPOSITIONS
#113Heterologous Administration of Tau Vaccines
#114AMHR2-ED CANCER VACCINE FORMULATIONS
#115Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#116IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A LIPOSOMAL FORMULATION, METHOD OF PRODUCING THE COMPOSITION, THE COMPOSITION FOR USE AS A MEDICAMENT, IN PARTICULAR FOR USE AS A VACCINE
#117IPSC-BASED VACCINE AS A PROPHYLACTIC AND THERAPEUTIC TREATMENT FOR CANCER
#118CITRULLINATED NUCLEOPHOSMIN PEPTIDES AS CANCER VACCINES
#119IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE
#120Nanoparticle vaccine adjuvant and methods of use thereof
#121Compositions comprising modified HIV envelopes
#122Use of the Salmonella SPP Type III Secretion Proteins as a Protective Vaccination
#123USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#124ADJUVANT FORMULATIONS COMPRISING TLR4 AGONISTS AND METHODS OF USING THE SAME
#125Synergistic Combination of Alum and Non-Liposome, Non-Micelle Particle Vaccine Adjuvants
#126FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE
#127Methods and composition for induction of immune response
#128METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES TO MULTIPLE DIFFERENT MHC MOLECULES
#129Lipidated immune response modifier compound compositions, formulations, and methods
#130AUTOANTIGENIC PEPTIDES (CALVICIFIV), PRESENTED BY TOLEROGENIC DENTRITIC CELLS, USEFUL FOR THE PERSONALIZED TREATMENT OF RHEUMATOID ARTHRITIS
#131STIMULI THAT HYPERACTIVATE RESIDENT DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
#132ZIKA VIRUS IMMUNOGENIC COMPOSITIONS
#133Coronavirus disease (COVID-19) vaccine
#134TREATMENT METHODS
#135PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY
#136Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists
#137METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY
#138Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists
#139Thermostable Vaccine Compositions and Methods of Preparing The Same
#140FcRn-targeted mucosal vaccination against RSV
#141INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICS
#142Hyperactive Dendritic Cells Enable Durable Adoptive Cell Transfer-Based Anti-Tumor Immunity
#143RSV F protein compositions and methods for making same
#144Antibodies Against Fentanyl and Fentanyl Analogs
#145Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
#146RSV F protein compositions and methods for making same
#147LIPOPOLYSACCHARIDE MOLECULES FOR ENHANCING IMMUNE RESPONSES
#148METHODS FOR MANUFACTURING AN ADJUVANT
#149Immunogenic Antigens
#150FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#151THERAPEUTIC VIRAL VACCINE
#152FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
#153COMPOSITIONS AND METHODS FOR ENHANCING INNATE IMMUNITY IN A SUBJECT FOR TREATMENT OF INFECTIONS AND CANCER AND OTHER ACUTE AND CHRONIC CONDITIONS OF THE EYE
#154Composition and method for spray drying an adjuvant vaccine emulsion
#155ADJUVANTS FOR IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#156ANTI-ABETA VACCINE THERAPY
#157PEPTIDES AND CONJUGATES FOR TREATMENT OF ARTHRITIS
#158RSV F protein compositions and methods for making same
#159Combinations including ABX196 for the treatment of cancer
#160Immunomodulatory lipopolysaccharide compositions
#161Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#162Compositions, methods and uses for thermally stable multi-targeted antigens
#163PSORALEN-INACTIVATED CORONAVIRUS VACCINE AND METHOD OF PREPARATION
#164Adapted enterovirus D68 that propagates to high titer in vero cells
#165recombinanr xiexumapoeozoite protein compositions and method for vaccine delivery
#166COMPOSITION AND PROCESS FOR PREPARING VACCINE
#167Vaccine delivery systems using yeast cell wall particles
#168Method of conferring a protective immune response to Norovirus
#169VACCINE COMPOSITIONS COMPRISING AN AMPHIPATHIC COMPOUND, A NEOANTIGEN AND A HYDROPHOBIC CARRIER, AND METHODS OF USE THEREOF
#170A MONOPHOSPHORYL LIPID-A LIPOSOME BASED CANCER VACCINE
#171IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#172Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine
#173Immunogenic Antigens
#174POLYMERIC NANOVACCINES AND USES THEREOF
#175ENCAPSULATED GLYCOLIPID ANTIGENS FOR TREATMENT OF NEOPLASTIC DISEASES
#176ANUCLEATE CELL-DERIVED VACCINES
#177COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#178ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED
#179Hepatitis c virus E1/E2 heterodimers and methods of producing same
#180IMMUNE PRIMING TO ACCELERATE/ENHANCE IMMUNE RESPONSE THROUGH ADMINISTRATION OF NATURAL IMMUNE MODULATOR
#181METHOD FOR TREATING T-HELPER TYPE 2 MEDIATED DISEASE
#182Compositions of Phosphorylated Tau Peptides and Uses Thereof
#183Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#184Tuberculosis compositions and methods of using the same
#185METHOD FOR MANUFACTURING A TUMOR VACCINE
#186Periodontitis vaccine and related compositions and methods of use
#187Thermostable vaccine compositions and methods of preparing same
#188Cancer antigens and methods
#189Adjuvant compositions
#190MICROCAPSULE-BASED VACCINE
#191BACTERICIDAL/PERMEABILITY INCREASING PROTEIN FOR USE IN A METHOD OF IMMUNIZATION, PREFERABLY AS AN ADJUVANT IN A METHOD OF VACCINATION
#192RECOMBINANT BIOLOGICALLY CONTAINED FILOVIRUS VACCINE
#193HPV vaccine
#194ANTI-TUMOR COMPOSITIONS AND USES THEREOF
#195Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response
#196Vaccine composition and uses thereof
#197COMPOSITION AND PROCESS FOR PREPARING VACCINE
#198KRAS peptide vaccine compositions and method of use
#199Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems
#200Vaccine compositions
#201Stable vaccine compositions comprising inter alia live attenuated recombinant flavivirus and process for preparation thereof
#202Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
#203Oil-based adjuvants
#204Methods for manufacturing an adjuvant
#205Immunostimulatory compositions, particles, and uses related thereto
#206Hepatitis B immunization regimen and compositions
#207Compositions and methods for delivery of biomacromolecule agents
#208Methods for inducing an immune response
#209Anti-abeta therapeutic vaccines
#210Parenteral norovirus vaccine formulations
#211METHODS OF USING A VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
#212VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
#213glycoconjugate vaccines
#214Lipidated immune response modifier compound compositions, formulations, and methods
#215Immunopotentiator, foot-and-mouth disease inactivated vaccine and preparation method thereof
#216Lipid nanoparticle vaccine adjuvants and antigen delivery systems
#217Mucosal adjuvants and delivery systems
#218POLYMER ADJUVANT
#219Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists
#220Pro-inflammatory and adjuvant functions of toll-like receptor 4 antagonists
#221Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant
#222Immunogenic compositions
#223Method of inducing an immune response using an expression construct and GLA
#224Compositions of phosphorylated tau peptides and uses thereof
#225Vaccine delivery systems using yeast cell wall particles
#226Compositions and methods for a multi-adjuvant only approach to immunoprophylaxis for preventing infections
#227Method of conferring a protective immune response to norovirus
#228Heterologous administration of tau vaccines
#229Vaccines comprising polypeptides for the prevention, treatment, and diagnosis of leprosy
#230UspA2 protein constructs and uses thereof
#231Treatment of infection
#232Use of the salmonella SPP type III secretion proteins as a protective vaccination
#233Methods for inducing an immune response
#234LIPOSOMAL FORMULATIONS COMPRISING SAPONIN AND METHODS OF USE
#235Multivalent Epstein-Barr virus-like particles and uses thereof
#236Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines
#237IMMUNOPOTENTIATOR, FOOT-AND-MOUTH DISEASE INACTIVATED VACCINE AND PREPARATION METHOD THEREOF
#238Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#239Method of safe administration of phosphorylated tau peptide vaccine
#240Nanoparticles for treatment of allergy
#241Reducing the toxicity of agrobacterium endotoxin
#242Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#243RSV F protein compositions and method for making same
#244Immunogenic compositions for the prevention and treatment of meningococcal disease
#245Modified lipopolysaccharide glycoform and method of use
#246Tumor vaccine and uses thereof
#247Lipid A mimics, methods of preparation, and uses thereof
#248Antigenic combinations against bacteria and related nanolipoprotein particles, compositions, methods and systems
#249Nanoparticle vaccine adjuvant and methods of use thereof
#250Vaccine delivery systems using yeast cell wall particles
#251Method of making a liposome composition
#252IMMUNOGENIC COMPOSITION COMPRISING SURVIVIN PEPTIDES
#253Immunomodulatory compositions and methods of use thereof
#254Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#255Lipidated immune response modifier compound compositions, formulations, and methods
#256Financial Method
#257Methods for inducing an immune response
#258Method of conferring a protective immune response to norovirus
#259Thermostable vaccine compositions and methods of preparing same
#260Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#261FcRn-targeted mucosal vaccination against influenza infections
#262Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
#263Use of nanoparticles for immunotherapy
#264Nicotine nanovaccines and uses thereof
#265Nanoparticles having poly(ester amide) polymer cores as drug delivery vehicles
#266Phage conjugates and uses thereof
#267IMMUNITY INDUCER
#268Herpes zoster vaccine composition
#269Combinations including ABX196 for the treatment of cancer
#270Tuberculosis compositions and methods of using the same
#271Method for preventing or treating infection
#272Anti-abeta therapeutic vaccines
#273West nile virus vaccine and method of use thereof
#274IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer
#275EBOLA VIRUS VACCINE
#276Methods and compositions for inducing an immune response
#277Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
#278Vaccine delivery systems using yeast cell wall particles
#279Mucosal adjuvants and delivery systems
#280Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
#281Periodontitis vaccine and related compositions and methods of use
#282EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES
#283Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof
#284Formulation containing TLR agonist and methods of use
#285L2 peptide immunogenicity
#286Norovirus vaccine formulations
#287Compositions of phosphorylated tau peptides and uses thereof
#288PEPTIDE PARTICLE FORMULATION
#289Artificial invaplex formulated with deacylated lipopolysaccharide
#290Adjuvant composition, vaccine composition containing the same, and method for producing both of them
#291TOFACITINIB AS VACCINATION IMMUNE MODULATOR
#292IMMUNOSTIMULATORY COMBINATIONS
#293FcRn-targeted mucosal vaccination against RSV
#294Oil-based adjuvants
#295Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
#296Method for preventing or treating infection
#297Adjuvant compositions
#298Methods and vaccines for inducing immune responses to multiple different MHC molecules
#299Method of reducing reactogenicity induced by administration of vaccine or immunogenic composition
#300LIPID VESICLE COMPOSITIONS AND METHODS OF USE